Skip to Content

54 107 (Lithium 300 mg)

This pill with imprint "54 107" is Beige, Round and has been identified as Lithium carbonate extended release 300 mg. It is supplied by Roxane Laboratories, Inc..

Lithium is used in the treatment of bipolar disorder; borderline personality disorder; schizoaffective disorder; depression; cyclothymic disorder (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 300 mg is not a controlled substance under the Controlled Substance Act (CSA).

Lithium carbonate extended release 300 mg 54 107
Lithium carbonate extended release 300 mg 54 107  Front
Lithium carbonate extended release 300 mg 54 107  Back
Lithium carbonate extended release 300 mg 54 107

Lithium carbonate extended release

Imprint:
54 107
Strength:
300 mg
Color:
Beige
Size:
10.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Miscellaneous antipsychotic agents
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Roxane Laboratories, Inc.
Inactive Ingredients:
calcium stearate
povidone
sodium chloride
sodium lauryl sulfate
sorbitol
Note: Inactive ingredients may vary.

Imprint Code FAQ's

Other Labelers / Repackagers:
NDC CodeLabeler / Repackager
68084-0640 Amerisource Health Services

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide